Women's Health Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Johns Hopkins Medical Institutes
Proteomic profiling technology may enable validation of breast cancer biomarkers
February 5th, 2006
Proteomic profiling technology may enable discovery and validation of specific breast cancer biomarkers. Researchers in the United States conducted a study "to establish a comprehensive proteomic approach for biomarker discovery and validation in breast fluid." "A total of 95 specimens from three institutions were used including 10 nipple aspiration fluid (5 stage 1/11 cancerous breasts and 5 age-matched healthy controls), 42 ductal lavage fluid from 14 patients with unilateral stage I/II cancer (25 from 9 cancerous breasts and 17 from 7 contralateral breasts), and 42 ductal lavage fluid from 14 high-risk women (multiple ducts repeated...
Source: Women's Health Law Weekly (2006-02-05)
|
